Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Mycobacterium Tuberculosis
  • Tuberculosis
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Younger than 17 years
Gender
Both males and females

Description

This will be done by measuring a variety of parameters in the blood samples and compare them with the current diagnostic gold standard for TB or for culture/NAAT non-confirmed TB cases a consensus case definition is used. Currently available immunodiagnostic tests (IGRA/TST) will be compared to nove...

This will be done by measuring a variety of parameters in the blood samples and compare them with the current diagnostic gold standard for TB or for culture/NAAT non-confirmed TB cases a consensus case definition is used. Currently available immunodiagnostic tests (IGRA/TST) will be compared to novel immunodiagnostic tests which will include: several novel, additional M. tuberculosis-specific Antigens cytokines that are highly expressed Since there is no diagnostic gold standard for TB infection we will rely on a clinical composite reference standard for diagnosing TB infection. Biomarkers will be determined by: including M. tuberculosis-specific antigens that are specifically expressed in either TB infection or disease, measuring phenotypes and cytokine production of M. tuberculosis-specific cells.

Tracking Information

NCT #
NCT03044509
Collaborators
  • Ospedale Regionale Bellinzona e Valli
  • University Hospital Inselspital, Berne
  • University of Lausanne Hospitals
  • University Hospital, Geneva
  • Luzerner Kantonsspital
  • Cantonal Hospital of St. Gallen
  • University Children's Hospital, Zurich
  • Kantonsspital Aarau
Investigators
Principal Investigator: Nicole Ritz, PD Dr med UKBB